爱尔兰癌症病人获得新治疗的机会有限,西欧的等待时间最长。 Irish cancer patients have limited access to new treatments, with the longest wait times in Western Europe.

爱尔兰的新癌症治疗在西欧的可用性最低,自2020年以来,在56种新许可的癌症药物中,只有14种提供给病人。 Ireland has the lowest availability of new cancer treatments in Western Europe, with only 14 out of 56 new cancer medicines licensed since 2020 available to patients. 爱尔兰癌症患者等待新药物的时间几乎为两年,比前一年长55天,高于欧盟平均水平。 Irish cancer patients face wait times of almost two years for new medications, which is 55 days longer than the previous year and above the EU average. 爱尔兰医药保健协会(IPHA)和联合癌症倡导者网络(UCAN)呼吁进行改革,以加快获得新治疗的步伐。 The Irish Pharmaceutical Healthcare Association (IPHA) and the United Cancer Advocates Network (UCAN) are calling for reforms to speed up access to new treatments.